Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meeting Future Demands of Acute Care Through the Home Hospital Care Model.

Journal of healthcare management / American College of Healthcare Executives·2025
Same author

Low oxytocin levels are broadly associated with more pronounced psychopathology in anorexia nervosa with primarily restricting but not binge/purge eating behavior.

Frontiers in endocrinology·2023
Same author

Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa.

Nutrients·2022
Same author

High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors.

Frontiers in oncology·2022
Same author

Sprouting Angiogenesis in Human Pituitary Adenomas.

Frontiers in oncology·2022
Same author

The effect of short-term high-caloric feeding and fasting on bone microarchitecture.

Bone·2021

Related Experiment Video

Updated: Jul 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Activation of p53 by MEG3 non-coding RNA.

Yunli Zhou1, Ying Zhong, Yingying Wang

  • 1Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. yzhou2@partners.org

The Journal of Biological Chemistry
|June 16, 2007
PubMed
Summary

The maternally expressed gene 3 (MEG3) non-coding RNA acts as a tumor suppressor by activating p53 and inhibiting cell proliferation through both p53-dependent and independent pathways.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jul 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • MEG3 is a maternally expressed imprinted gene.
  • MEG3 is suggested to function as a non-coding RNA.
  • MEG3 exhibits tumor suppressor activity.

Purpose of the Study:

  • To investigate the hypothesis that MEG3 functions through the activation of the tumor suppressor p53.
  • To elucidate the mechanisms underlying MEG3's tumor suppressor function.

Main Methods:

  • Transfection of MEG3 expression constructs.
  • Functional assay using p53-responsive promoter activity.
  • Analysis of p53 protein levels and transcriptional activity.
  • Assessment of GDF15 and p21(CIP1) expression.
  • Investigation of MDM2 levels.
  • Cell proliferation assays in the presence and absence of p53.

Main Results:

  • MEG3 transfection significantly increased p53 protein levels and stimulated p53-dependent transcription.
  • MEG3 functions as a non-coding RNA, with RNA folding being critical for its activity.
  • MEG3 enhanced p53 binding to the GDF15 promoter, increasing GDF15 expression.
  • MEG3 selectively regulated p53 transcriptional activity, not inducing p21(CIP1) expression.
  • MEG3 down-regulated MDM2 levels, contributing to p53 accumulation.
  • MEG3 inhibited cell proliferation independently of p53.

Conclusions:

  • MEG3 functions as a tumor suppressor through both p53-dependent and p53-independent mechanisms.
  • MEG3's non-coding RNA nature is essential for its tumor suppressor activity.
  • MEG3 influences p53 stability and transcriptional specificity, offering potential therapeutic insights.